Abaxis (ABAX) Raises Quarterly Dividend 9.1% to $0.12; 1.1% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2016 and Declares a 9% Increase in Quarterly Cash Dividend
April 28, 2016 4:02 PM EDTUNION CITY, Calif., April 28, 2016 /PRNewswire/ --Â Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, today reported financial results for the fourth quarter and fiscal year ended March 31, 2016.
Fourth quarter and fiscal 2016 overview:
Revenues from continuing operations of $57.0 million for the fourth quarter, up 10% over last year's comparable quarter, and $218.9 million for fiscal 2016, up 8% year-over-year. Diluted EPS from continuing operations of $0.36 for the fourth quarter, up 112% over last year's comparable quarter, and $1.36 for fiscal 2016, up 49%... More